Companies Partner to Provide Somatic Testing for Prostate Cancer
P4 Diagnostix and Pierian will be launching somatic testing for prostate cancer patients, expanding P4’s Urology NGS Services.
Read More
Search Results for: prostate cancer
Genomic Testing Can Identify African American Prostate Cancer Patients Who Have High-Risk Disease
A new study investigated genomic biomarkers associated with aggressive disease in African American men with prostate cancer.
Read More
Considering Genetic Risk in Prostate Cancer Referrals Could Lead to Early Diagnosis
Men at the highest risk for prostate cancer could be fast-tracked for investigation if their genetic risk was considered in general practice.
Read More
Urine-Based Molecular Test for Prostate Cancer Available
miR Sentinel is a novel, urine-based molecular test that analyzes small non-coding RNA using a proprietary biostatistical algorithm.
Read More
Fewer PSA Tests May Cut Overdiagnosis But Miss Aggressive Prostate Cancer Cases
The incidence of more aggressive prostate cancer cases that are higher-grade disease and metastasis at diagnosis have risen.
Read More